BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells
Xiao Zhou(Second Affiliated Hospital of Nanjing Medical University), Xuerong Wang(Nanjing Medical University)
Cited by 13
Related Papers
Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
|Cancer Research|2008|159
<scp>AEG</scp>‐1 induces gastric cancer metastasis by upregulation of <scp>eIF</scp>4E expression
|Journal of Cellular and Molecular Medicine|2017|27
Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
|Cancer Cell International|2021|15